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INTRODUCTION 
Opioid analgesics continue to be the mainstay of pharmacologic treatment of moderate to 
severe pain. An adjunct is a drug that in its pharmacological characteristic is not identified 
primarily as an analgesic, but that has been found in clinical practice to have either an 
independent analgesic effect or additive analgesic properties when used with opioids. By using 
an adjunct to maximize the level of analgesia, the required opioid dosage may be reduced, 
together with concomitant adverse effects.  
BACKGROUND 
Real World Data (RWD) refers to data that describe observations in normal clinical practice 
obtained by any non-interventional methodology, such as Randomized Controlled Trials (RCTs). 
The U.S. Food and Drug Administration (FDA) maintains one of the largest government 
databases in the country, the FDA Adverse Event Reporting System (FAERS). It is comprised of 
adverse event reports submitted to the FDA through the “MedWatch” reporting program and 
contains a plethora of Real World Data: thousands of case reports on opioids and adjunct drugs, 
comprised of unstructured textual data. The objective of this study is to identify the therapeutic 
effectiveness of adjunct drugs with opioids by examination of narrative text in MedWatch cases.  
METHODS 
This project follows the traditional approach of knowledge discovery in databases, comprised 
of five steps: 1) Data selection, 2) Pre-processing, 3) Transformation, 4) Data mining and 5) 
Interpretation. The strategy employed will transform the narrative text data into an organized and 
  
 
concise summary of key endpoints. An appropriate sample (500 to 1,000 relevant patient cases) 
that describe opioids and adjunct drugs will be included in the case report data set.  
Key task 1: Data selection and pre-processing (Steps 1,2). MedWatch narratives of patient 
cases that describe the types of opioid and adjunct drug combinations used in real-life clinical 
settings will be obtained from the FAERS database. Key task 2: Data transformation and mining 
(Steps 3,4). Cases will be organized in a Structured Query Language (SQL) database. A lexicon 
of words and terms clinically or theoretically related to opioid and adjunct drug therapy will be 
developed, which will serve as a reference for analysis of the text. Using Natural Language 
Processing (NLP) techniques, textual data will be transformed into n-grams using a MySQL n-
gram parser. N-gram extraction will identify notes containing n-grams matching terms from the 
theory-and expert-derived lexicon. Categories will be formed from the most frequently identified 
n-grams and their total frequency.  
RESULTS (PROJECTED) 
Key task 3: Evaluate and interpret results (Step 5) and compile the information into a useful 
format for healthcare providers. The most commonly extracted n-grams will be identified by 
category, then frequency, and displayed in tabular format. N-gram analysis of the corpus of case 
reports reveals the frequency with which and adjunct drug was used with an opioid, and indicate 
impact on analgesic effect. Completion of key tasks provides evidence on the associated 
outcomes of treatment; whether the adjunct drug therapy indicates treatment success or failure. 
CONCLUSION 
Findings of this project will add to the existing body of knowledge on opioid adjunct therapy 
for analgesia and may corroborate or refute other existing evidence for adjunct drug therapeutic 
effectiveness derived from case reports or clinical trials. 
